Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Farmakis

Showing results (151-160 of 297) with videos related to

Pageof 30
Sort By:
Atherosclerosis|May 23, 2006
Endothelial function and arterial stiffness in sickle-thalassemia patientsAthanasios Aessopos, Dimitrios Farmakis, Maria Tsironi, et al.
International Journal of Cardiology|April 5, 2014
Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferaseJohn T Parissis, Dimitrios Farmakis, Chiara Andreoli, et al.
European Journal of Heart Failure|January 9, 2021
Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non-randomized, open-label, proof-of-concept studyApostolos Karavidas, Efstratios Troganis, George Lazaros, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|September 24, 2023
High-sensitivity cardiac troponin I for cardiovascular risk stratification in apparently healthy individualsDimitrios Farmakis, Dimitrios Richter, Genovefa Chronopoulou, et al.
Atherosclerosis|November 10, 2007
Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failureKallirrhoe Kourea, John T Parissis, Dimitrios Farmakis, et al.
Heart Failure Reviews|December 11, 2025
Victoria and Victor: event-driven lessons for integrating vericiguat into practice and reducing residual risk in HFrEFKalliopi Keramida, Francesca Musella, Magdy Abdelhamid, et al.
International Journal of Cardiology|July 6, 2016
Structured discharge instructions for hospitalized heart failure patients to improve guideline implementation and patient outcomesDimitrios Farmakis, Gerasimos Filippatos, John Parissis, et al.
International Journal of Cardiology|November 1, 2008
Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failureDimitrios Farmakis, John T Parissis, Vassiliki Bistola, et al.
Hemasphere|March 6, 2025
TIF Guidelines for the Management of Transfusion-Dependent β-ThalassemiaKhaled M Musallam, Maria Domenica Cappellini, John B Porter, et al.
Journal of Clinical Medicine|January 8, 2025
<i>Campylobacter jejuni</i>-Related Myocarditis: A Case Report and Review of the LiteratureVirginia Zouganeli, Christos Kourek, Vasiliki Bistola, et al.
Pageof 30

Showing results (151-160 of 297) with videos related to

Sort By:
Pageof 30
Atherosclerosis|May 23, 2006
Endothelial function and arterial stiffness in sickle-thalassemia patientsAthanasios Aessopos, Dimitrios Farmakis, Maria Tsironi, et al.
International Journal of Cardiology|April 5, 2014
Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferaseJohn T Parissis, Dimitrios Farmakis, Chiara Andreoli, et al.
European Journal of Heart Failure|January 9, 2021
Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non-randomized, open-label, proof-of-concept studyApostolos Karavidas, Efstratios Troganis, George Lazaros, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|September 24, 2023
High-sensitivity cardiac troponin I for cardiovascular risk stratification in apparently healthy individualsDimitrios Farmakis, Dimitrios Richter, Genovefa Chronopoulou, et al.
Atherosclerosis|November 10, 2007
Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failureKallirrhoe Kourea, John T Parissis, Dimitrios Farmakis, et al.
Heart Failure Reviews|December 11, 2025
Victoria and Victor: event-driven lessons for integrating vericiguat into practice and reducing residual risk in HFrEFKalliopi Keramida, Francesca Musella, Magdy Abdelhamid, et al.
International Journal of Cardiology|July 6, 2016
Structured discharge instructions for hospitalized heart failure patients to improve guideline implementation and patient outcomesDimitrios Farmakis, Gerasimos Filippatos, John Parissis, et al.
International Journal of Cardiology|November 1, 2008
Plasma B-type natriuretic peptide reduction predicts long-term response to levosimendan therapy in acutely decompensated chronic heart failureDimitrios Farmakis, John T Parissis, Vassiliki Bistola, et al.
Hemasphere|March 6, 2025
TIF Guidelines for the Management of Transfusion-Dependent β-ThalassemiaKhaled M Musallam, Maria Domenica Cappellini, John B Porter, et al.
Journal of Clinical Medicine|January 8, 2025
<i>Campylobacter jejuni</i>-Related Myocarditis: A Case Report and Review of the LiteratureVirginia Zouganeli, Christos Kourek, Vasiliki Bistola, et al.
Pageof 30